StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries.
StageBio's integrated offering includes tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to regulatory approval, detailed pathology reporting for GLP studies, medical device pathology, immunohistochemistry, and neuropathology.